Claas Otto

543 total citations
9 papers, 438 citations indexed

About

Claas Otto is a scholar working on Immunology, Infectious Diseases and Virology. According to data from OpenAlex, Claas Otto has authored 9 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Infectious Diseases and 5 papers in Virology. Recurrent topics in Claas Otto's work include HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (4 papers) and Immune Cell Function and Interaction (4 papers). Claas Otto is often cited by papers focused on HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (4 papers) and Immune Cell Function and Interaction (4 papers). Claas Otto collaborates with scholars based in Germany, France and United States. Claas Otto's co-authors include Frank Kirchhoff, Armin Papkalla, Jan Münch, Michael H. Sieweke, Sandrine Sarrazin, Laurent Vanhille, Noushin Mossadegh‐Keller, Frédéric Mourcin, Estelle Duprez and Louise K. Modis and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

Claas Otto

9 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claas Otto Germany 8 222 163 115 93 63 9 438
Eric Riedel United States 7 218 1.0× 105 0.6× 81 0.7× 90 1.0× 86 1.4× 8 430
Hiroaki Yoshii Japan 10 163 0.7× 111 0.7× 126 1.1× 77 0.8× 33 0.5× 14 359
Keri B. Sanborn United States 9 381 1.7× 192 1.2× 51 0.4× 67 0.7× 75 1.2× 13 604
Hisashi Nagase Japan 12 278 1.3× 165 1.0× 66 0.6× 158 1.7× 40 0.6× 27 620
Sabrina Sforzini Italy 12 396 1.8× 170 1.0× 180 1.6× 67 0.7× 169 2.7× 18 649
Jiyi Yin United States 9 211 1.0× 152 0.9× 46 0.4× 134 1.4× 31 0.5× 9 491
Clarisse Benne France 10 192 0.9× 227 1.4× 159 1.4× 66 0.7× 72 1.1× 11 492
Kamalpreet Arora United States 7 153 0.7× 272 1.7× 103 0.9× 70 0.8× 57 0.9× 8 402
Annegret Rehm Germany 8 324 1.5× 84 0.5× 47 0.4× 39 0.4× 83 1.3× 11 478
Atef Allam United States 11 237 1.1× 83 0.5× 74 0.6× 30 0.3× 52 0.8× 13 340

Countries citing papers authored by Claas Otto

Since Specialization
Citations

This map shows the geographic impact of Claas Otto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claas Otto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claas Otto more than expected).

Fields of papers citing papers by Claas Otto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claas Otto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claas Otto. The network helps show where Claas Otto may publish in the future.

Co-authorship network of co-authors of Claas Otto

This figure shows the co-authorship network connecting the top 25 collaborators of Claas Otto. A scholar is included among the top collaborators of Claas Otto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claas Otto. Claas Otto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Sarrazin, Sandrine, Noushin Mossadegh‐Keller, Taro Fukao, et al.. (2009). MafB Restricts M-CSF-Dependent Myeloid Commitment Divisions of Hematopoietic Stem Cells. Cell. 138(2). 300–313. 133 indexed citations
2.
Otto, Claas, Ellis Jaffray, Youssef Bakri, et al.. (2007). SUMO Modification Regulates MafB-Driven Macrophage Differentiation by Enabling Myb-Dependent Transcriptional Repression. Molecular and Cellular Biology. 27(15). 5554–5564. 38 indexed citations
3.
Pöhlmann, Stefan, Jan Münch, Jacqueline D. Reeves, et al.. (2006). A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo. Virology. 360(2). 275–285. 3 indexed citations
4.
Vanhille, Laurent, Louise Kelly, Claas Otto, et al.. (2006). Development of Macrophages with Altered Actin Organization in the Absence of MafB. Molecular and Cellular Biology. 26(18). 6808–6818. 63 indexed citations
5.
Pöhlmann, Stefan, Carl W. Davis, Silke Meister, et al.. (2004). Amino Acid 324 in the Simian Immunodeficiency Virus SIVmac V3 Loop Can Confer CD4 Independence and Modulate the Interaction with CCR5 and Alternative Coreceptors. Journal of Virology. 78(7). 3223–3232. 21 indexed citations
6.
Casarosa, Paola, Wiro M. P. B. Menge, Rosalba Minisini, et al.. (2003). Identification of the First Nonpeptidergic Inverse Agonist for a Constitutively Active Viral-encoded G Protein-coupled Receptor. Journal of Biological Chemistry. 278(7). 5172–5178. 73 indexed citations
7.
Otto, Claas, Bridget A. Puffer, Stefan Pöhlmann, Robert W. Doms, & Frank Kirchhoff. (2003). Mutations in the C3 region of human and simian immunodeficiency virus envelope have differential effects on viral infectivity, replication, and CD4-dependency. Virology. 315(2). 292–302. 16 indexed citations
8.
Papkalla, Armin, Jan Münch, Claas Otto, & Frank Kirchhoff. (2002). Nef Enhances Human Immunodeficiency Virus Type 1 Infectivity and Replication Independently of Viral Coreceptor Tropism. Journal of Virology. 76(16). 8455–8459. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026